Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2002, Vol. 7 ›› Issue (6): 548-549.

Previous Articles     Next Articles

Clinical re-evaluation of Beijing Hypotensive No.0 in treatment of essential hypertension

HE Zhao-Zhu, ZOU Shi   

  1. Outpatient Department,J iangxi Medical College,Nanchang 330006
  • Received:2002-09-07 Revised:2002-09-19 Online:2002-12-26 Published:2020-11-20

Abstract: AIM: To re-evaluate the effects of Beijing Hypotensive No.0 in the treatment of essential hypertension.METHODS: The 39 cases of patients suffered essential hypertension were treated by Beijing Hypotensive NO.0 at 1 tablet each time and once a day.A single course of treatment lasted for eight weeks.The trial was evaluated with blood pressure,heart rate,blood routine examination,hepatic and kidney function,blood sugar,blood lipid,and blood uric acid before and after the treatment.RESULTS: Beijing Hypotensive NO.0 could significantly relieve hypertension(p<0.01);no differences were shown in blood routine examination,hepatic and kidney function,blood lipid,blood sugar,and blood uric acid(p>0.05).CONCLUSION: Beijing hypetensive No.0 is an effective and safe agent in the treatment of essential hypertension.

Key words: Beijing Hypotensive No.0, hypertension, re-evaluation

CLC Number: